» Articles » PMID: 34198685

MTOR Signaling in the Inner Ear As Potential Target to Treat Hearing Loss

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2021 Jul 2
PMID 34198685
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Hearing loss affects many people worldwide and occurs often as a result of age, ototoxic drugs and/or excessive noise exposure. With a growing number of elderly people, the number of people suffering from hearing loss will also increase in the future. Despite the high number of affected people, for most patients there is no curative therapy for hearing loss and hearing aids or cochlea implants remain the only option. Important treatment approaches for hearing loss include the development of regenerative therapies or the inhibition of cell death/promotion of cell survival pathways. The mammalian target of rapamycin (mTOR) pathway is a central regulator of cell growth, is involved in cell survival, and has been shown to be implicated in many age-related diseases. In the inner ear, mTOR signaling has also started to gain attention recently. In this review, we will emphasize recent discoveries of mTOR signaling in the inner ear and discuss implications for possible treatments for hearing restoration.

Citing Articles

VASCilia (Vision Analysis StereoCilia): A Napari Plugin for Deep Learning-Based 3D Analysis of Cochlear Hair Cell Stereocilia Bundles.

Kassim Y, Rosenberg D, Das S, Huang Z, Rahman S, Shammaa I bioRxiv. 2024; .

PMID: 38948743 PMC: 11212889. DOI: 10.1101/2024.06.17.599381.


A Low Dose of Rapamycin Promotes Hair Cell Differentiation by Enriching SOX2 Progenitors in the Neonatal Mouse Inner Ear Organoids.

Wu W, Chen P, Yang J, Liu Y J Assoc Res Otolaryngol. 2024; 25(2):149-165.

PMID: 38472516 PMC: 11018585. DOI: 10.1007/s10162-024-00938-1.


mTORC2 regulates auditory hair cell structure and function.

Cortada M, Levano S, Hall M, Bodmer D iScience. 2023; 26(9):107687.

PMID: 37694145 PMC: 10484995. DOI: 10.1016/j.isci.2023.107687.


mTOR Signaling: New Insights into Cancer, Cardiovascular Diseases, Diabetes and Aging.

Das A, Reis F Int J Mol Sci. 2023; 24(17).

PMID: 37686434 PMC: 10487471. DOI: 10.3390/ijms241713628.


mTOR Signaling in BDNF-Treated Guinea Pigs after Ototoxic Deafening.

Tisi A, Ramekers D, Flati V, Versnel H, Maccarone R Biomedicines. 2022; 10(11).

PMID: 36428503 PMC: 9687683. DOI: 10.3390/biomedicines10112935.


References
1.
Scaiola A, Mangia F, Imseng S, Boehringer D, Berneiser K, Shimobayashi M . The 3.2-Å resolution structure of human mTORC2. Sci Adv. 2020; 6(45). PMC: 7673708. DOI: 10.1126/sciadv.abc1251. View

2.
Francis S, Katz J, Fanning K, Harris K, Nicholas B, Lacy M . A novel role of cytosolic protein synthesis inhibition in aminoglycoside ototoxicity. J Neurosci. 2013; 33(7):3079-93. PMC: 3711767. DOI: 10.1523/JNEUROSCI.3430-12.2013. View

3.
Sha S, Chen F, Schacht J . PTEN attenuates PIP3/Akt signaling in the cochlea of the aging CBA/J mouse. Hear Res. 2009; 264(1-2):86-92. PMC: 2868099. DOI: 10.1016/j.heares.2009.09.002. View

4.
Corwin J, Cotanche D . Regeneration of sensory hair cells after acoustic trauma. Science. 1988; 240(4860):1772-4. DOI: 10.1126/science.3381100. View

5.
Bar-Peled L, Chantranupong L, Cherniack A, Chen W, Ottina K, Grabiner B . A Tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1. Science. 2013; 340(6136):1100-6. PMC: 3728654. DOI: 10.1126/science.1232044. View